Location Palo Alto, California, United States Regions San Francisco Bay Area, Silicon Valley, West Coast Gender Male
LinkedIn View on LinkedIn
Mr. Harrison is Vice President, New Frontier Science and is responsible for engaging healthcare innovation emerging from academia and scientific centers of excellence. Among other projects, he led Takeda's entry into the Tri-Institutional Therapeutics Discovery Initiative in New York. He was previously Vice President, Takeda Ventures, Inc,
from 2008 to 2012 and was responsible for 4 investments. Mr. Harrison brings more than 27 years of biopharmaceutical R&D, product licensing, business development and strategy experience. Prior to joining Takeda, Mr. Harrison was a partner with ProPharma Partners International, where he specialized in developing and implementing business and licensing strategy for emerging and established biopharmaceutical companies. Before this, he was Vice President Business Development at XenoPort Inc., and held senior licensing positions at PowderJect Inc., Connetics Corporation and Alza Corporation. In addition, Mr. Harrison held product development management and research positions at Alza, where he began his career in 1985. Mr. Harrison received his Bachelor of Sciences in Combined Sciences from Santa Clara University in California, USA.
